Package Leaflet: Information for the User
Rivaroxaban Aristo 20 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Rivaroxaban Aristo contains the active substance rivaroxaban and is used in adults to:
Rivaroxaban Aristo is used in children and adolescents under 18 years of age and with a body weight of 30 kg or more to:
Rivaroxaban belongs to a group of medicines called antithrombotic agents. It works by blocking a factor in the blood that is involved in blood clotting (factor Xa) and thus reduces the tendency of the blood to form clots.
Do not take Rivaroxaban Aristo
Do not take Rivaroxaban Aristo and inform your doctorif any of these apply to you.
Warnings and precautions
Consult your doctor or pharmacist before taking Rivaroxaban Aristo.
Be particularly careful with rivaroxaban
Inform your doctor if any of these situations apply to youbefore taking Rivaroxaban Aristo. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If you need surgery:
Children and adolescents
Rivaroxaban Aristo is not recommended in children with a body weight below 30 kg.There is not enough information on the use of Rivaroxaban Aristo in children and adolescents for the indications in adults.
Other medicines and Rivaroxaban Aristo
Inform your doctor or pharmacist if you are using, have recently used or might use any other medicines, including those obtained without a prescription.
If any of the above applies to you,inform your doctorbefore taking Rivaroxaban Aristo, as the effect of Rivaroxaban Aristo may be increased. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, they may recommend that you also use a preventative treatment.
If any of the above applies to you,inform your doctorbefore taking Rivaroxaban Aristo, as the effect of Rivaroxaban Aristo may be reduced. Your doctor will decide if you should be treated with Rivaroxaban Aristo and if you should be kept under closer observation.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take Rivaroxaban Aristo if you are pregnant or breast-feeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking Rivaroxaban Aristo. If you become pregnant while taking Rivaroxaban Aristo, inform your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban Aristo may cause dizziness (common side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). Do not drive, ride a bicycle or use tools or machines if you are affected by these symptoms.
Rivaroxaban Aristo contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking Rivaroxaban Aristo.
Rivaroxaban Aristo contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".
Follow exactly the instructions of your doctor for taking this medicine. If you are unsure, ask your doctor or pharmacist again.
You must take Rivaroxaban Aristo with food.
Swallow the tablets, preferably with water.
If you have difficulty swallowing the whole tablet, consult your doctor about other ways to take Rivaroxaban Aristo. The tablet can be crushed and mixed with water or apple puree, immediately before taking it. Then take food.
If necessary, your doctor may also administer the crushed Rivaroxaban Aristo tablet through a gastric tube.
What dose to take
Adults
The recommended dose is one 20 mg rivaroxaban tablet once a day.
If you have kidney problems, the dose may be reduced to one 15 mg rivaroxaban tablet once a day.
If you need to undergo a procedure to treat blocked blood vessels in your heart (called percutaneous coronary intervention - PCI with stent insertion), there is limited evidence to reduce the dose to one 15 mg rivaroxaban tablet once a day (or one 10 mg rivaroxaban tablet once a day if your kidneys do not work properly) in addition to an antiplatelet medicine such as clopidogrel.
The recommended dose is one 15 mg rivaroxaban tablet twice a day for the first 3 weeks. After 3 weeks, the recommended dose is one 20 mg rivaroxaban tablet once a day.
After at least 6 months of treatment for blood clots, your doctor may decide to continue treatment with one 10 mg tablet once a day or one 20 mg tablet once a day.
If you have kidney problems and are taking one 20 mg rivaroxaban tablet once a day, your doctor may decide to reduce the dose to one 15 mg rivaroxaban tablet once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.
Children and adolescents
The dose of Rivaroxaban Aristo depends on body weight and will be calculated by your doctor.
Take each dose of Rivaroxaban Aristo with a drink (e.g. water or juice) during a meal. Take the tablets every day at approximately the same time. Consider setting an alarm to remind you. For parents or caregivers: observe the child to ensure they take the entire dose.
Since the dose of Rivaroxaban Aristo is based on body weight, it is important to attend scheduled visits with your doctor, as it may be necessary to adjust the dose as the weight changes. Never adjust the dose of Rivaroxaban Aristo on your own. Your doctor will adjust the dose if necessary.
Do not divide the tablet to try to obtain a fraction of the tablet dose. If a smaller dose is required, please use the alternative presentation of rivaroxaban granules for oral suspension. In children and adolescents who cannot swallow whole tablets, please use rivaroxaban granules for oral suspension.
If the oral suspension is not available, you can crush the Rivaroxaban Aristo tablet and mix it with water or apple puree immediately before taking it. Take some food after taking this mixture. If necessary, your doctor may also administer the crushed Rivaroxaban Aristo tablet through a gastric tube.
If you spit out the dose or vomit
When to start treatment with Rivaroxaban
Take the tablets every day, until your doctor tells you to stop.
Try to take the tablets at the same time every day to remember when to take them.
Your doctor will decide how long you should keep taking the treatment.
To prevent blood clots in the brain (stroke) or in other blood vessels:
If it is necessary to normalize your heartbeat through a procedure called cardioversion, take rivaroxaban at the times indicated by your doctor.
If you forget to take Rivaroxaban Aristo
Adults, children and adolescents
Adults
If you take more Rivaroxaban Aristo than you should
Contact your doctor immediately if you have taken too many Rivaroxaban Aristo tablets. Taking too much Rivaroxaban Aristo increases the risk of bleeding.
If you stop taking Rivaroxaban Aristo
Do not stop taking Rivaroxaban Aristo without talking to your doctor first, as rivaroxaban treats and prevents serious conditions.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Like other similar medicines to reduce blood clot formation (antithrombotics), Rivaroxaban may cause bleeding that can endanger the patient's life. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.
Tell your doctor immediately if you or your childexperience any of the following symptoms:
Signs of bleeding
Your doctor will decide whether to keep you under closer observation or change your treatment.
Signs of severe skin reactions
The frequency of these adverse effects is very rare (up to 1 in 10,000 people)
Signs of severe allergic reactions
The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible adverse effects found in adults, children, and adolescents:
Frequent(may affect up to 1 in 10 patients):
Uncommon(may affect up to 1 in 100 patients):
Rare(may affect up to 1 in 1,000 patients):
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(frequency cannot be estimated from available data):
Adverse effects in children and adolescents
In general, the adverse effects observed in children and adolescents treated with Rivaroxaban Aristo were similar to those observed in adults, and their severity was mainly mild to moderate.
Adverse effects that were more frequently observed in children and adolescents
Very frequent(may affect more than 1 in 10 people)
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them to the Spanish Medicines and Health Products Agency: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging and on each blister after "CAD" or "EXP". The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Crushed tablets
Crushed tablets are stable in water or apple puree for up to 2 hours.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Rivaroxaban Aristo
Tablet core: microcrystalline cellulose, sodium croscarmellose, lactose monohydrate, hypromellose 2910, sodium lauryl sulfate, magnesium stearate. See section 2 "Rivaroxaban Aristo contains lactose and sodium".
Tablet film coating: hypromellose 2910, titanium dioxide (E 171), macrogol 3350, red iron oxide (E 172).
Appearance of the product and package contents
Rivaroxaban Aristo 20 mg film-coated tablets are dark red, round, biconvex (6.5 mm in diameter) and have "20" engraved on one side, and are smooth on the other.
They are available in transparent PVC/PVDC aluminum blisters in cardboard boxes.
Boxes of 7, 14, 28, 30, 42, 45, 56, 98, or 100 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Aristo Pharma GmbH
Wallenroder Straße 8-10
13435 Berlin
Germany
Manufacturer
S.C. Labormed-Pharma S.A.
Bd. Theodor Pallady nr. 44B, sector 3
Bucharest cod 032266
Romania
Or
Saneca Pharmaceuticals a.s.
Nitrianska 100
920 27 Hlohovec
Slovakia
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid, Spain
This medicine is authorized in the EEA Member States and in the United Kingdom (Northern Ireland) under the following names:
Austria Rivaroxaban Aristo 20 mg Filmtabletten
Italy Rivaroxaban Aristo
Norway Rivaroxaban Aristo 20 mg filmdrasjerte tabletter
Spain Rivaroxaban Aristo 20 mg comprimidos recubiertos con película EFG
Sweden Rivaroxaban Aristo 20 mg filmdragerade tabletter
Portugal Rivaroxaban Aristo
Denmark Rivaroxaban Aristo
Germany Rivaroxaban Aristo 20 mg Filmtabletten
United Kingdom Rivaroxaban
(Northern Ireland)
Date of the last revision of this leaflet:January 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/